Search Legislation

Advanced Search

The Medical Devices (Northern Ireland Protocol) Regulations 2021

Changes to legislation:

There are outstanding changes not yet made by the legislation.gov.uk editorial team to The Medical Devices (Northern Ireland Protocol) Regulations 2021. Those changes will be listed when you open the content using the Table of Contents below. Any changes that have already been made by the team appear in the content and are referenced with annotations. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the affected provisions when you open the content using the Table of Contents below.

View outstanding changes

Changes and effects yet to be applied to :

Changes and effects yet to be applied to the whole Instrument associated Parts and Chapters:

Whole provisions yet to be inserted into this Instrument (including any effects on those provisions):

  1. Introductory Text

  2. PART 1 Preliminary

    1. 1.Citation and commencement

    2. 2.Extent and application

    3. 3.Interpretation

    4. 4.Scope

  3. PART 2 Making available on the market and putting into service under Regulation (EU) 2017/745

    1. 5.Reprocessing of single-use devices

    2. 6.Requirement on health institutions to provide information relating to implanted devices

    3. 7.Registration of custom-made devices

    4. 8.Certificates of free sale - fee

    5. 9.Retention of documentation relating to conformity assessments and custom-made devices

    6. 10.UK(NI) indication

  4. PART 3 Clinical investigations under Regulation (EU) 2017/745

    1. 11.Ethical review of clinical investigations

    2. 12.Prior authorisation of clinical investigations by the Secretary of State

    3. 13.Arbitration following the refusal of a clinical investigation application

    4. 14.Damage compensation in relation to clinical investigations

    5. 15.Retention of documentation relating to clinical investigations

    6. 16.Clinical investigation fees

    7. 17.Clinical investigations not carried out for a purpose specified in Article 62(1)

    8. 17A.Advice in relation to intended clinical investigations

  5. PART 4 Notified bodies designated under Regulation (EU) 2017/745

    1. 18.Notified bodies

    2. 19.Fees payable in connection with the designation of notified bodies

  6. Part 4A Fees for consultation in relation to the safety, quality and usefulness of a medicinal substance incorporated in a device

    1. 19A.Interpretation of Part 4A

    2. 19B.Circumstances in which a fee is payable in relation to a consultation on the safety, quality and usefulness of a medicinal substance incorporated in a device

    3. 19C.Fees payable in connection with a consultation or further consultation on the safety, quality and usefulness of a medicinal substance incorporated in a device

    4. 19D.Fees for pre-consultation meetings

  7. PART 5 General provision about language requirements and fees

    1. 20.Language requirements

    2. 21.Unpaid fees

    3. 22.Waivers, reductions and refunds

  8. PART 6 Enforcement

    1. 23.Offence of breaching certain provisions

    2. 24.Defence of due diligence

    3. 25.Offences by bodies corporate

    4. 26.Enforcement

  9. PART 7 Amendment of primary legislation

    1. 27.Investigatory powers under the Consumer Rights Act 2015

    2. 28.Amendment of the Medicines and Medical Devices Act 2021

  10. PART 8 Amendment of the Medical Devices Regulations 2002

    1. 29.Amendments to the Medical Devices Regulations 2002

    2. 30.Amendment of regulation 2 (interpretation)

    3. 31.Amendment of regulation 2A (medical devices which are qualifying Northern Ireland goods)

    4. 32.Revocation and transitional provision

    5. 33.Amendment of regulation 10A (UK(NI) indication: general medical devices)

    6. 34.Amendment of regulation 19 (registration of persons placing general medical devices on the market)

    7. 35.Amendment of regulation 21B (registration of persons placing active implantable medical devices on the market)

    8. 36.Amendment of regulation 24A (UK(NI) indication: active implantable medical devices)

    9. 37.Amendment of regulation 36A (UK(NI) indication: in vitro diagnostic medical devices)

  11. PART 9 Amendments of other secondary legislation

    1. 38.Amendment of the Blood Safety and Quality Regulations 2005

    2. 39.Amendment of the Human Tissue (Quality and Safety for Human Application) Regulations 2007

    3. 40.Amendment of the Legislative and Regulatory Reform (Regulatory Functions) Order 2007

    4. 41.Amendment of the Medicines (Products for Human Use) (Fees) Regulations 2016

    5. 42.Amendment of the Economic Growth (Regulatory Functions) Order 2017

    6. 43.Amendment of the Market Surveillance (Northern Ireland) Regulations 2021

  12. Signature

    1. SCHEDULE 1

      Fees for clinical investigations

    2. SCHEDULE 2

      Fees in connection with the designation of notified bodies

    3. SCHEDULE 3

      Provisions breach of which is an offence under regulation 23

  14. Explanatory Note

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources